Xavier Vidal

124 papers receiving 5k citations

Xavier Vidal's Hit Papers

Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome 2019 · 258 citations
2580+4+8Years since publication100200300400500

Peers

Xavier Vidal
Comparison fields: 5 of 137
  • Geriatrics and Gerontology 305
  • Hepatology 583
  • Toxicology 332
  • Pharmacology 547
  • Pharmacology 305
Replace Kevin Haynes with:
Kevin Haynes United States
Yu‐Xiao Yang United States
Thierry Vial France
Laura Ellyn Targownik Canada
Joseph Austin Delaney United States
Fernando Gomollón Spain
Joan‐Ramon Laporte Spain
Xavier Carné Spain
Lorenza Scotti Italy
Shinya Ito Canada
Xavier Vidal relative to Kevin Haynes United States Kevin Haynes's profile →
Citations per field
00.5×2×3×4×5.0×
Kevin Haynes · 1×
Citations per year

Countries citing papers authored by Xavier Vidal

Since Specialization
Citations

This map shows the geographic impact of Xavier Vidal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xavier Vidal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xavier Vidal more than expected).

Fields of papers citing papers by Xavier Vidal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xavier Vidal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xavier Vidal. The network helps show where Xavier Vidal may publish in the future.

Co-authors

The 25 scholars most cited alongside Xavier Vidal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xavier Vidal Line = papers co-authored together Xavier Vidal links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 129 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Randomized Trial of Posaconazole and Benznidazole for Chronic Chagas' Disease
Hit paper breakdown →
2014512
2 1990321
3 1991277
4
Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome
Hit paper breakdown →
2019258
5 1991242
6 2004212
7 2005163
8 2011156
9 2008148
10 2004135
11 2010118
12 2005111
13 2002110
14 200890
15 201689
16 201684
17 200081
18 199080
19 201579
20 200774

About Xavier Vidal

Xavier Vidal is a scholar working on Geriatrics and Gerontology, Toxicology, Pharmacology, Pharmacology and Cardiology and Cardiovascular Medicine, having authored 129 papers that have together received 5.3k indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (13 papers), Pharmacovigilance and Adverse Drug Reactions (12 papers), Gastrointestinal Bleeding Diagnosis and Treatment (8 papers), Blood disorders and treatments (7 papers), Drug-Induced Hepatotoxicity and Protection (6 papers), Inflammatory mediators and NSAID effects (6 papers), Atrial Fibrillation Management and Outcomes (5 papers) and COVID-19 Clinical Research Studies (5 papers). The work is most often cited by research in Geriatrics and Gerontology (305 citations), Hepatology (583 citations), Toxicology (332 citations), Pharmacology (547 citations) and Pharmacology (305 citations). Xavier Vidal has collaborated with scholars based in Spain, Italy and Peru. Frequent co-authors include Joan‐Ramon Laporte, Luisa Ibáñez, Elena Ballarín, Lourdes Vendrell, E. Pérez, Vı́ctor Moreno, Xavier Carné, Antònia Agustí, Dolors Capellà and Eva Montané. Their work appears in journals such as European Journal of Clinical Pharmacology, Frontiers in Pharmacology, Drug Safety, British Journal of Clinical Pharmacology and Alimentary Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact